BNP Paribas Financial Markets Boosts Stake in Trupanion, Inc. (NASDAQ:TRUP)

BNP Paribas Financial Markets boosted its stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 170.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 337,093 shares of the financial services provider's stock after buying an additional 212,545 shares during the period. BNP Paribas Financial Markets owned approximately 0.80% of Trupanion worth $16,248,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Amundi lifted its holdings in shares of Trupanion by 193.2% during the 4th quarter. Amundi now owns 16,828 shares of the financial services provider's stock valued at $784,000 after buying an additional 11,088 shares during the period. Barclays PLC increased its holdings in shares of Trupanion by 259.2% in the 3rd quarter. Barclays PLC now owns 65,498 shares of the financial services provider's stock worth $2,750,000 after buying an additional 47,262 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of Trupanion by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider's stock worth $173,362,000 after buying an additional 45,653 shares during the last quarter. Wealthfront Advisers LLC purchased a new stake in shares of Trupanion in the fourth quarter valued at $845,000. Finally, Illinois Municipal Retirement Fund purchased a new stake in shares of Trupanion in the fourth quarter valued at $834,000.

Wall Street Analyst Weigh In

Several research analysts recently commented on TRUP shares. Stifel Nicolaus reduced their price target on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research note on Thursday, February 20th. Lake Street Capital cut their price objective on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research report on Friday, May 2nd. Finally, Piper Sandler cut their price target on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research note on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $51.80.

Trupanion Stock Performance

NASDAQ TRUP traded up $0.75 during mid-day trading on Monday, reaching $45.02. 502,956 shares of the stock were exchanged, compared to its average volume of 645,097. Trupanion, Inc. has a 1 year low of $25.90 and a 1 year high of $57.90. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. The business's 50 day moving average is $36.92 and its 200-day moving average is $44.43. The company has a market capitalization of $1.93 billion, a P/E ratio of -195.74, a P/E/G ratio of 6.02 and a beta of 1.72.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.05) by $0.02. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The business had revenue of $341.98 million for the quarter, compared to the consensus estimate of $337.81 million. During the same quarter last year, the business posted ($0.16) earnings per share. The business's quarterly revenue was up 11.7% compared to the same quarter last year. On average, equities research analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

Insiders Place Their Bets

In other Trupanion news, CFO Fawwad Qureshi sold 1,373 shares of Trupanion stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total transaction of $46,984.06. Following the completion of the sale, the chief financial officer now directly owns 2,416 shares of the company's stock, valued at $82,675.52. The trade was a 36.24% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Margaret Tooth sold 4,000 shares of Trupanion stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $33.34, for a total value of $133,360.00. Following the sale, the chief executive officer now directly owns 118,784 shares of the company's stock, valued at $3,960,258.56. This trade represents a 3.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,792 shares of company stock valued at $1,122,802 over the last quarter. 5.50% of the stock is owned by insiders.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.